Basic recordSource-linkedReadyVerified review available

MicroPort MedBot

Source-linked surgical robotics supplier profile based on MicroPort MedBot's official English website, about page, product/news pages, contact page, and investor materials. Medical and regulatory claims require scope-specific operator verification.

Known capabilities

Toumai laparoscopic surgical robot product lineHonghu orthopedic surgical robot product lineSkyWalker orthopedic surgical robot product lineR-ONE vascular intervention robot product lineDFVision 3D electronic laparoscope product lineRobotic intelligent surgical total solutions across clinical applicationsMedical robotics

Best-fit application prompts

Supplier-specific notes are shown when source-reviewed. Fallback prompts are category-level screening guidance, not unsupported supplier claims.

Surgical robotics supplier screening

Laparoscopic surgical robot review

Orthopedic surgical robot comparison

Vascular intervention robot inquiry screening

Hospital procurement and regulatory-path qualification

Source-linked facts

MicroPort MedBot's official about page states that it provides comprehensive intelligent surgical solutions by integrating robot ontology, control algorithms, electrical engineering, image-based navigation, and precision imaging.

Official: https://www.medbotsurgical.com/en/about

The official contact page lists Shanghai MicroPort MedBot (Group) Co., Ltd., telephone 400-900-3155, email MB_customer@microport.com, and a Shanghai Pilot Free Trade Zone address.

Official: https://www.medbotsurgical.com/en/contact

The official contact page also lists MicroPort OrthoBot (Suzhou) Co., Ltd. as a contact entity.

Official: https://www.medbotsurgical.com/en/contact

An official news page states that Toumai Laparoscopic Surgical Robot is an endoscopic surgery robot product independently developed by MicroPort MedBot.

Official: https://www.medbotsurgical.com/en/news/4.html

An official news page states that MicroPort MedBot presented Toumai Laparoscopic Surgical Robot and Honghu 1 Orthopedic Surgical Robot at a 2022 event.

Official: https://www.medbotsurgical.com/en/news/135.html

An official news page states that MedBot presented Toumai multi-port and single-port laparoscopic surgical robots, SkyWalker orthopedic surgical robot, R-ONE vascular intervention robot, and DFVision 3D electronic laparoscope.

Official: https://www.medbotsurgical.com/en/news/269.html

The official patient-care page lists clinical applications including urology, orthopedics, respiratory, general surgery, and gynecology.

Official: https://www.medbotsurgical.com/en/patientcare

The 2024 annual results presentation states that the company has a comprehensive product offering covering all five major and fast-growing surgical specialties and lists overseas approval claims for flagship products.

Source-linked: https://ir.medbotsurgical.com/media/p2wpihpf/microport-medbot-ar2024-presentation.pdf

Contact path status

Phone: 400-900-3155
Risk Note: Medical robotics outreach requires regulatory approval, hospital procurement path, clinical training, service, warranty, local registration, and distributor validation before any buyer-facing recommendation.
Contact Form: Available
Contact Email: MB_customer@microport.com
Support Email: MB_customer@microport.com
Official Website: Available
Overseas Contact Path: Investor materials include source-linked overseas approval claims for some products; target-country commercial, regulatory, and service paths require verification.

Source checklist

Profile data label

Source-linked

Source URL

https://www.medbotsurgical.com/en/contact

Export readiness

Ready

Certification

Source-linked claim

Last reviewed date

2026-06-02

Unknown / risk flags

Certification and regulatory approvals: Source-linked claim

Investor materials list overseas approvals for some products; display only after verifying product, country, approval type, and current status.

Factory scale: Source unavailable

Do not infer manufacturing capacity from corporate profile or product portfolio.

Customer claims: Source-linked claim

Clinical and approval claims require medical/regulatory verification and should not be used as broad customer endorsement.

Partnerships: Source unavailable

Do not infer active partnerships from event/news pages without specific partnership source review.

Export readiness: Ready

Marked Ready because official English pages, contact form/email, investor materials, and source-linked overseas approval claims exist; target-country regulatory and service path still needs confirmation.

Possible buyer questions

Which MicroPort MedBot product and clinical specialty is relevant to the buyer: Toumai, SkyWalker/Honghu, R-ONE, DFVision, or another system?

What current regulatory approval exists for the buyer's target country and exact product model?

Can MedBot provide English IFU, technical documents, clinical training, service terms, quotation, and installation requirements?

Who handles hospital procurement, local registration, maintenance, spare parts, training, and clinical support in the buyer country?

What clinical evidence, safety documentation, and warranty/service coverage are available?

Conservative operator note

Suitable as a medical-robotics shortlist candidate only after product-specific regulatory approval, clinical scope, country support, and procurement/service paths are verified. Do not label as verified supplier unless the backend verification checklist is completed.

Buyer actions

Ask GoCybertron to compare this supplier with alternatives. Submitted requests enter the workspace lead queue for review.

Request sourced shortlist Request comparison How shortlist review works View company page

Supplier action

Claiming a profile starts an operations review. It does not imply verification or official status.

Claim this supplier profile